Solventum to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024
Solventum Announces Commitment to 100% Renewable Electricity by 2030
Palantir Stock Has Gained 14% Since Being Added to the S&P 500. This Stock Did Even Better.
Solventum Appoints Ryan Egeland as CMO
Express News | Solventum Names Surgeon and Diagnostics Pioneer DR. Ryan Egeland as Chief Medical Officer
Press Release: Solventum Names Surgeon and Diagnostics Pioneer Dr. Ryan Egeland as Chief Medical Officer
Solventum Corp (SOLV) Q2 2024 Earnings Call Highlights: Strategic Progress Amidst Margin Pressures
3M's Healthcare Spinoff Solventum Earns Buy at Stifel on Faster Turnaround
Stifel Maintains Solventum(SOLV.US) With Buy Rating, Maintains Target Price $82
Solventum Initiated at Buy by Stifel
Stifel Initiates Solventum(SOLV.US) With Buy Rating, Announces Target Price $82
Goldman Sachs Adjusts Price Target on Solventum to $55 From $54
Piper Sandler Initiates Solventum(SOLV.US) With Hold Rating, Announces Target Price $71
Hold Rating on Solventum Corporation Amidst Growth and Leverage Concerns
Express News | Solventum Corp : Piper Sandler Initiates Coverage With Neutral Rating; Price Target $71
Solventum Corp. (SOLV): A Cheap New Stock To Invest In Now
Bristol-Myers Tops Growth Chart Among S&P 500 Healthcare Stocks in Q3
Decoding 4 Analyst Evaluations For Solventum
Solventum Initiated With a Peer Perform at Wolfe Research
Is Solventum Stock Outperforming the Nasdaq?